Lonza’s Bioscience Solutions offerings include cell-culture, transfection and molecular biology tools for life-science research. We serve customers across the world in academic and government institutions, as well as in major biotech and pharmaceutical organizations.
Our Bioscience Solutions team sets the industry standard for product quality and customer support in life-science research with our Clonetics™ and Poietics™ primary cells and stem cells; Nucleofector™ Transfection technology; and electrophoresis devices and reagents.
For the drug-discovery and translational research markets, we offer products and services targeting cardiovascular, respiratory, neurological, metabolic, cancer and other disease-research areas.
Our Therapeutic Cell Culture Media business serves customers in the pharmaceutical and biotech industry. Therapeutic cell culture media is used in the production of therapeutics like antibodies, antibody drug conjugates (ADCs), vaccines and other biologics.
Lonza’s Testing Solutions' endotoxin-detection assays are applied in pharmaceutical product release testing to help assure the safety of injectable drugs, implantable medical devices and dialysis samples. Our fully integrated software solutions streamline Quality Control processes and offer insight into manufacturing operations, with quick access to management, compliance and trending data.
In 2016 Lonza acquired Triangle Research Labs (TRL), a fast-growing hepatocyte company based in North Carolina (USA), which manufactures and sells hepatic products for in vitro evaluation of metabolism, drug-drug interactions, drug transporter activity, toxicity of drug candidates and other applications. With the TRL acquisition, Bioscience Solutions has added high-quality fresh and cryo-preserved, human and animal hepatocytes for medical and biomedical research in pre-clinical ADME-Tox applications. The addition of TRL and its products further strengthens Bioscience Solutions’ position as a worldwide leader in cell discovery by integrating this business into our primary-cell portfolio and creating the basis for new product offerings and the entry into additional strategic markets.
Bioscience Solutions Overview 2016
Market demand for research products, testing solutions, MODA™ and bio-therapeutic media product portfolios continued to be favorable; and they delivered strong growth in 2016 compared with 2015.
The 2016 acquisition of Triangle Research Labs (TRL), a hepatocyte provider based in North Carolina (USA), further strengthened Lonza’s position as a worldwide leader in cell discovery.
For further information about Bioscience Solutions products, such as Endotoxin-Detection Assays, PowerCHO Advance™ Media, Hepatocytes, RAFT™ 3D Cell-Culture System, CytoSMART™ System, Cells On Demand™ Services, 4D-Nucleofector™ LV (large volume) Device, MODA™ Paperless QC Micro Solution and PyroGene™ rFC Assay, click on our Bioscience Solutions website.